Previous observations in targeting pancreatic ductal adenocarcinoma suggest that MYC levels can be used to predict the response to triptolide, with tumor cultures harboring the highest MYC levels being more sensitive (14). The gene discussed is MYC; the disease is pancreatic ductal adenocarcinoma.